Icon Wealth Advisors LLC decreased its stake in shares of CME Group Inc. (NASDAQ:CME – Free Report) by 94.7% during the 3rd quarter, Holdings Channel reports. The institutional investor owned 325 shares of the financial services provider’s stock after selling 5,827 shares during the period. Icon Wealth Advisors LLC’s holdings in CME Group were worth $72,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors also recently made changes to their positions in the stock. Harbor Capital Advisors Inc. grew its holdings in CME Group by 0.6% during the third quarter. Harbor Capital Advisors Inc. now owns 7,810 shares of the financial services provider’s stock worth $1,723,000 after acquiring an additional 45 shares during the period. CVA Family Office LLC lifted its stake in CME Group by 11.8% during the third quarter. CVA Family Office LLC now owns 436 shares of the financial services provider’s stock valued at $96,000 after purchasing an additional 46 shares during the last quarter. Lester Murray Antman dba SimplyRich grew its position in CME Group by 0.7% in the second quarter. Lester Murray Antman dba SimplyRich now owns 7,667 shares of the financial services provider’s stock worth $1,507,000 after buying an additional 50 shares during the last quarter. Zions Bancorporation N.A. increased its holdings in shares of CME Group by 3.7% in the third quarter. Zions Bancorporation N.A. now owns 1,530 shares of the financial services provider’s stock valued at $338,000 after buying an additional 54 shares in the last quarter. Finally, Quent Capital LLC boosted its stake in shares of CME Group by 10.2% during the 3rd quarter. Quent Capital LLC now owns 593 shares of the financial services provider’s stock worth $131,000 after acquiring an additional 55 shares in the last quarter. 87.75% of the stock is currently owned by institutional investors.
Wall Street Analysts Forecast Growth
CME has been the subject of several analyst reports. Redburn Atlantic downgraded CME Group from a “buy” rating to a “neutral” rating and set a $244.00 target price for the company. in a report on Tuesday, October 8th. Citigroup lifted their price target on CME Group from $250.00 to $255.00 and gave the company a “buy” rating in a report on Thursday, October 24th. Deutsche Bank Aktiengesellschaft reduced their price objective on CME Group from $227.00 to $226.00 and set a “hold” rating for the company in a research note on Monday, November 11th. Bank of America increased their price target on shares of CME Group from $177.00 to $180.00 and gave the stock an “underperform” rating in a research report on Thursday, October 3rd. Finally, Morgan Stanley increased their target price on shares of CME Group from $210.00 to $233.00 and gave the stock an “equal weight” rating in a research report on Thursday, October 17th. Four investment analysts have rated the stock with a sell rating, seven have given a hold rating and four have given a buy rating to the company. Based on data from MarketBeat, the company has an average rating of “Hold” and an average price target of $224.47.
Insiders Place Their Bets
In other news, insider Timothy Francis Mccourt sold 1,374 shares of CME Group stock in a transaction on Monday, October 28th. The stock was sold at an average price of $227.12, for a total transaction of $312,062.88. Following the completion of the sale, the insider now owns 7,275 shares of the company’s stock, valued at approximately $1,652,298. This trade represents a 15.89 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Timothy S. Bitsberger sold 1,000 shares of CME Group stock in a transaction dated Wednesday, October 30th. The stock was sold at an average price of $226.96, for a total transaction of $226,960.00. Following the completion of the sale, the director now owns 10,589 shares of the company’s stock, valued at $2,403,279.44. This trade represents a 8.63 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 15,621 shares of company stock valued at $3,441,063 over the last ninety days. 0.30% of the stock is currently owned by company insiders.
CME Group Stock Performance
Shares of CME opened at $229.04 on Monday. CME Group Inc. has a twelve month low of $190.70 and a twelve month high of $230.74. The company has a debt-to-equity ratio of 0.09, a quick ratio of 1.02 and a current ratio of 1.02. The firm’s 50 day moving average price is $223.64 and its two-hundred day moving average price is $211.08. The firm has a market cap of $82.54 billion, a P/E ratio of 24.08, a PEG ratio of 5.23 and a beta of 0.55.
CME Group (NASDAQ:CME – Get Free Report) last posted its quarterly earnings data on Wednesday, October 23rd. The financial services provider reported $2.68 EPS for the quarter, topping analysts’ consensus estimates of $2.65 by $0.03. The company had revenue of $1.58 billion during the quarter, compared to the consensus estimate of $1.59 billion. CME Group had a net margin of 57.34% and a return on equity of 13.39%. The company’s quarterly revenue was up 18.4% on a year-over-year basis. During the same period in the prior year, the business posted $2.25 EPS. On average, analysts forecast that CME Group Inc. will post 10.22 EPS for the current fiscal year.
CME Group Dividend Announcement
The firm also recently announced a quarterly dividend, which will be paid on Friday, December 27th. Stockholders of record on Monday, December 9th will be paid a dividend of $1.15 per share. The ex-dividend date of this dividend is Monday, December 9th. This represents a $4.60 annualized dividend and a dividend yield of 2.01%. CME Group’s dividend payout ratio is currently 48.37%.
CME Group Company Profile
CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.
Further Reading
- Five stocks we like better than CME Group
- Consumer Discretionary Stocks Explained
- Disney’s Magic Strategy: Reinventing the House of Mouse
- What is the NASDAQ Stock Exchange?
- Volatility in Semis? 3 Stable Alternatives to NVIDIA and SMCI
- How to Use the MarketBeat Stock Screener
- Vertiv’s Cool Tech Makes Its Stock Red-Hot
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME – Free Report).
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.